Catalyst Pharmaceuticals Stock (NASDAQ: CPRX) stock price, news, charts, stock research, profile.
Open | $16.80 |
Close | $16.94 |
Volume / Avg. | 527.32K / 1.19M |
Day Range | 16.69 - 17.02 |
52 Wk Range | 11.55 - 17.50 |
Market Cap | $2.00B |
P/E Ratio | 29.86 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 5.58% |
Days to Cover | 2.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) through any online brokerage.
Other companies in Catalyst Pharmaceuticals’s space includes: Protagonist Therapeutics (NASDAQ:PTGX), Celldex Therapeutics (NASDAQ:CLDX), Janux Therapeutics (NASDAQ:JANX), Beam Therapeutics (NASDAQ:BEAM) and Vericel (NASDAQ:VCEL).
There is no analysis for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals has a consensus price target of $24.81.
The stock price for Catalyst Pharmaceuticals (NASDAQ: CPRX) is $16.94 last updated July 19, 2024 at 5:07 PM EDT.
There are no upcoming dividends for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.